Liver Receptor Homolog 1 Is a Negative Regulator of the Hepatic Acute-Phase Response
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The orphan nuclear receptor liver receptor homolog 1 (LRH-1) has been reported to play an important role in bile acid biosynthesis and reverse cholesterol transport. Here, we show that LRH-1 is a key player in the control of the hepatic acute-phase response. Ectopic expression of LRH-1 with adenovirus resulted in strong inhibition of both interleukin-6 (IL-6)- and IL-1beta-stimulated haptoglobin, serum amyloid A, and fibrinogen beta gene expression in hepatocytes. Furthermore, induction of the hepatic inflammatory response was significantly exacerbated in HepG2 cells expressing short hairpin RNA targeting LRH-1 expression. Moreover, transient-transfection experiments and electrophoretic mobility shift and chromatin immunoprecipitation assays revealed that LRH-1 regulates this cytokine-elicited inflammatory response by, at least in part, antagonizing the CCAAT/enhancer binding protein beta signaling pathway. Finally, we show, by using LRH-1 heterozygous mice, that LRH-1 is involved in the control of the inflammatory response at the hepatic level in vivo. Taken together, our results outline an unexpected role for LRH-1 in the modulation of the hepatic acute-phase response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 1×
“Among them, peroxisome proliferator-activated receptors (PPAR) and liver X receptors (LXR) have been reported to be molecular links between lipid metabolism and the inflammatory response (10, 27).”
BackgroundTanaka, M., Yamamoto, Y., Misawa, E., Nabeshima, K., Saito, M., Yamauchi, K., Abe, F., & Furukawa, F. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000454718 · Cited by 1,092
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954 · cited 3×
“For instance, LXR and PPAR have been shown to be molecular links between lipid metabolism and inflammation by negatively interfering with several transcription factors, such as C/EBPs, AP-1, and NF-B ( 10 , 27, 29, 35).”
BackgroundMethodInfluentialPeroxisome proliferator-activated receptors in inflammation control
Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755 · cited 1×
“They exert their anti-inflammatory activities in various tissues, including the liver and macrophages, by antagonizing cytokine-mediated gene expression via transcriptional cross talk with NF-B, AP-1, CCAAT/ enhancer binding protein (C/EBP), and signal transducers and activators of transcription (STAT) signaling pathw…”
BackgroundSelf-citationThe Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions
Poli, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29279 · Cited by 677 · cited 3×
“The C/EBPs belong to a family of leucine zipper transcription factors involved in the control of inflammatory and native immunity functions (42).”
BackgroundBlack, P. H. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00048-5 · Cited by 502 · cited 2×
“(B to D) HepG2 cells cultured in 24-well plates were infected for 24 h with Ad-LRH-1 or Ad-GFP at various MOIs (1, 5 , 10).”
BackgroundMethod
Cited by
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639
Venteclef, N., Jakobsson, T., Ehrlund, A., Damdimopoulos, A., Mikkonen, L., Ellis, E., Nilsson, L.-M., Parini, P., Jänne, O. A., Gustafsson, J.-Å., et al. (2010) · Genes & Development · doi:10.1101/gad.545110 · Cited by 178
Self-citationLRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease
Coste, A., Dubuquoy, L., Barnouin, R., Annicotte, J.-S., Magnier, B., Notti, M., Corazza, N., Antal, M. C., Metzger, D., Desreumaux, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702440104 · Cited by 160
Metabolic nuclear receptor signaling and the inflammatory acute phase response
Venteclef, N., Jakobsson, T., Steffensen, K. R., & Treuter, E. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.004 · Cited by 99
Self-citationFlandez, M., Cendrowski, J., Cañamero, M., Salas, A., del Pozo, N., Schoonjans, K., & Real, F. X. (2014) · Gut · doi:10.1136/gutjnl-2012-304381 · Cited by 95
Metadata
- Authors
- Venteclef, N., Smith, J. C., Goodwin, B., & Delerive, P.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-09-01
- Volume
- 26
- Issue
- 18
- Pages
- 6799-6807
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2043484714
- Cited by
- 66
- References
- 7
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.